Related Experiment Video

Updated: Apr 21, 2026

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.3K

ErbB receptors as prognostic and therapeutic drug targets in bone and soft tissue sarcomas

Hongsheng Wang1, Qingbo Yang, Zeze Fu

  • 11Department of Orthopedics, Shanghai 1st People's Hospital, Shanghai Jiaotong University, Shanghai, China.

Cancer Investigation
|October 28, 2014
PubMed

Insights

ErbB receptors are key in cancer biology. This study reviews their potential as therapeutic targets in bone and soft tissue sarcomas, despite elusive clinical implications.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • ErbB receptors are crucial in cancer biology and are established therapeutic targets.
  • Numerous studies have investigated ErbB family member expression in various bone and soft tissue sarcomas.
  • The clinical significance of ErbB receptors in these sarcomas remains unclear.

Purpose of the Study:

  • To explore the potential of ErbB family members as prognostic markers.
  • To evaluate ErbB family members as therapeutic drug targets in bone and soft tissue sarcomas.
  • To consolidate molecular evidence and clinical observations regarding ErbB receptors in sarcomas.

Main Methods:

  • Literature review of molecular evidence.
  • Analysis of data from clinical trials.
  • Synthesis of findings from basic research studies.

Main Results:

  • ErbB receptor signaling pathways are implicated in sarcoma development and progression.
  • Expression patterns of ErbB family members vary across different sarcoma subtypes.
  • Preliminary data suggest potential correlations between ErbB expression and patient outcomes.

Conclusions:

  • ErbB receptors represent a promising avenue for targeted therapies in bone and soft tissue sarcomas.
  • Further research is warranted to elucidate the precise clinical implications and optimize therapeutic strategies.
  • Targeting ErbB signaling could offer new treatment options for sarcoma patients.
Keywords:
Bone and soft tissue sarcomasErbB receptorsPrognostic relevanceTargeted therapy

More Related Videos

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

11.9K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

6.7K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
6.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K